BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pandey PR, Young KH, Kumar D, Jain N. RNA-mediated immunotherapy regulating tumor immune microenvironment: next wave of cancer therapeutics. Mol Cancer 2022;21. [DOI: 10.1186/s12943-022-01528-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang M, Mo Y, Ren D, Liu S, Zeng Z, Xiong W. Transfer RNA-derived small RNAs in tumor microenvironment. Mol Cancer 2023;22:32. [PMID: 36797764 DOI: 10.1186/s12943-023-01742-w] [Reference Citation Analysis]
2 Zhang W, Liao Y, Liu C, Liu L, Zhou X. KNSTRN, a Poor Prognostic Biomarker, Affects the Tumor Immune Microenvironment and Immunotherapy Outcomes in Pan-Cancer. Dis Markers 2023;2023:6729717. [PMID: 36845017 DOI: 10.1155/2023/6729717] [Reference Citation Analysis]
3 Menon AP, Moreno B, Meraviglia-Crivelli D, Nonatelli F, Villanueva H, Barainka M, Zheleva A, van Santen HM, Pastor F. Modulating T Cell Responses by Targeting CD3. Cancers (Basel) 2023;15. [PMID: 36831533 DOI: 10.3390/cancers15041189] [Reference Citation Analysis]
4 Pei L, Liu Y, Liu L, Gao S, Gao X, Feng Y, Sun Z, Zhang Y, Wang C. Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers. Mol Cancer 2023;22:29. [PMID: 36759842 DOI: 10.1186/s12943-023-01731-z] [Reference Citation Analysis]
5 Seo H, Jeon L, Kwon J, Lee H. High-Precision Synthesis of RNA-Loaded Lipid Nanoparticles for Biomedical Applications. Adv Healthc Mater 2023;:e2203033. [PMID: 36737864 DOI: 10.1002/adhm.202203033] [Reference Citation Analysis]
6 Sun Y, Yang M, Zhang Q. Analysis of C-X-C motif chemokine receptors in breast cancer: potential value in immunotherapy and prognostic prediction. Ann Transl Med 2022;10:1379. [PMID: 36660642 DOI: 10.21037/atm-22-6056] [Reference Citation Analysis]
7 Luo Y, Tang W, Xiang S, Feng J, Zu X. Non-coding RNAs in breast cancer: Implications for programmed cell death. Cancer Letters 2022;550:215929. [DOI: 10.1016/j.canlet.2022.215929] [Reference Citation Analysis]
8 Long S, Zhang XF. AURKA is a prognostic potential therapeutic target in skin cutaneous melanoma modulating the tumor microenvironment, apoptosis, and hypoxia. J Cancer Res Clin Oncol. [DOI: 10.1007/s00432-022-04164-1] [Reference Citation Analysis]
9 Zhang F, Liu H, Duan M, Wang G, Zhang Z, Wang Y, Qian Y, Yang Z, Jiang X. Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application. J Hematol Oncol 2022;15. [DOI: 10.1186/s13045-022-01304-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Gupta SL, Basu S, Soni V, Jaiswal RK. Immunotherapy: an alternative promising therapeutic approach against cancers. Mol Biol Rep 2022. [PMID: 35759082 DOI: 10.1007/s11033-022-07525-8] [Reference Citation Analysis]
11 Yamada Y, Sato Y, Nakamura T, Harashima H. Innovative cancer nanomedicine based on immunology, gene editing, intracellular trafficking control. J Control Release 2022;348:357-69. [PMID: 35623492 DOI: 10.1016/j.jconrel.2022.05.033] [Reference Citation Analysis]
12 Vilar JB, Christmann M, Tomicic MT. Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go? Cancers 2022;14:2416. [DOI: 10.3390/cancers14102416] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]